Company Search:
Advanced Search
Sponsored Links
Omeros Corporation Company Snapshot
Omeros Corporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Omeros with three other companies in this sector in the United States: Tesaro Inc (2016 sales of $44.82 million of which 100% was Oncology Focused Therapeutics), Integrated Biopharma, Inc. ($42.21 million ), and ImmunoGen, Inc. ($43.01 million of which 100% was Cancer Therapeutics).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Omeros were $41.62 million. This is an increase of 208.1% versus 2015, when the company's sales were $13.51 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Omeros Corporation
  Stock Performance Chart for Omeros Corporation
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 19.60
(Figures in U.S. Dollars)
1 Week -5.5%   13 Weeks 7.9%  
4 Weeks -6.8%   52 Weeks 94.1%  
Omeros Corporation Key Data:
  Ticker: OMER Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 41,617,000
(Year Ending Jan 2017).
Employees: 154
  Currency: U.S. Dollars Market Cap: 940,873,892
  Fiscal Yr Ends: December Shares Outstanding: 48,003,770
  Share Type: Common Closely Held Shares: 2,742,725
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.